Bergenbio ASA (Norway) Market Value
| BGBIO Stock | NOK 1.51 0.03 1.95% |
| Symbol | Bergenbio |
Bergenbio ASA 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bergenbio ASA's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bergenbio ASA.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Bergenbio ASA on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Bergenbio ASA or generate 0.0% return on investment in Bergenbio ASA over 90 days. Bergenbio ASA is related to or competes with PCI Biotech, Photocure, and XXL ASA. BerGenBio ASA, a clinical-stage biopharmaceutical company, develops medicines to treat immune evasive, drug resistant, a... More
Bergenbio ASA Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bergenbio ASA's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bergenbio ASA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 106.42 | |||
| Value At Risk | (7.23) | |||
| Potential Upside | 6.49 |
Bergenbio ASA Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bergenbio ASA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bergenbio ASA's standard deviation. In reality, there are many statistical measures that can use Bergenbio ASA historical prices to predict the future Bergenbio ASA's volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (1.70) | |||
| Total Risk Alpha | (0.05) | |||
| Treynor Ratio | 0.9434 |
Bergenbio ASA Backtested Returns
Bergenbio ASA secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. Bergenbio ASA exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bergenbio ASA's Risk Adjusted Performance of (0.10), standard deviation of 11.75, and Mean Deviation of 4.66 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.61, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bergenbio ASA are expected to decrease by larger amounts. On the other hand, during market turmoil, Bergenbio ASA is expected to outperform it. At this point, Bergenbio ASA has a negative expected return of -1.51%. Please make sure to confirm Bergenbio ASA's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Bergenbio ASA performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.66 |
Good predictability
Bergenbio ASA has good predictability. Overlapping area represents the amount of predictability between Bergenbio ASA time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bergenbio ASA price movement. The serial correlation of 0.66 indicates that around 66.0% of current Bergenbio ASA price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.66 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 10.21 |
Bergenbio ASA lagged returns against current returns
Autocorrelation, which is Bergenbio ASA stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bergenbio ASA's stock expected returns. We can calculate the autocorrelation of Bergenbio ASA returns to help us make a trade decision. For example, suppose you find that Bergenbio ASA has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bergenbio ASA regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bergenbio ASA stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bergenbio ASA stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bergenbio ASA stock over time.
Current vs Lagged Prices |
| Timeline |
Bergenbio ASA Lagged Returns
When evaluating Bergenbio ASA's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bergenbio ASA stock have on its future price. Bergenbio ASA autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bergenbio ASA autocorrelation shows the relationship between Bergenbio ASA stock current value and its past values and can show if there is a momentum factor associated with investing in Bergenbio ASA.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Bergenbio Stock
Bergenbio ASA financial ratios help investors to determine whether Bergenbio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bergenbio with respect to the benefits of owning Bergenbio ASA security.